PCMT1 was verified using the Western blot analysis to cross-react with the antisera of A5, and a protein antigen of A5 with significant immunotherapeutic effects on S180 sarcoma was successfully created by the induction of antibodies targeting for PCMT1 [30]. This evidence concerns the gene PCMT1 and sarcoma.